WNK2 and cancer: However, extracellular HMGB1 is known to act as a growth factor that activates mitogen-activated protein kinase (MAPK) and thereby enhances the regrowth, metastasis, and chemoresistance of remnant cancer cells that survived prior chemotherapy via RAGE15,19,39–43.